Log on / register
Feedback | Support | My details

Pre-publication history

Use of immunohistochemical markers can refine prognosis in triple negative breast cancer

Marc Tischkowitz email, Jean-Sébastien Brunet email, Louis R Bégin email, David G Huntsman email, Maggie CU Cheang email, Lars A Akslen email, Torsten O Nielsen email and William D Foulkes email

BMC Cancer 2007, 7:134doi:10.1186/1471-2407-7-134

Pre-publication versions of this article and reviewers' reports

Original submission - Version 1Manuscript10 Mar 2007
Reviewer's ReportRadzislaw Kordek05 Apr 2007
Reviewer's ReportWilliam Anderson07 Apr 2007
Reviewer's ReportLaura Collins10 Apr 2007
Reviewer's ReportSunil Lakhani13 Apr 2007
Resubmission - Version 2ManuscriptAuthors' comments04 May 2007
Reviewer's ReportLaura Collins19 May 2007
Reviewer's ReportLaura Collins19 May 2007
Reviewer's ReportWilliam Anderson23 May 2007
Reviewer's ReportSunil Lakhani24 May 2007
Reviewer's ReportDan Moore11 Jun 2007
Resubmission - Version 3ManuscriptAuthors' comments15 Jun 2007
Reviewer's ReportDan Moore27 Jun 2007
Resubmission - Version 5ManuscriptAuthors' comments04 Jul 2007
Reviewer's ReportDan Moore16 Jul 2007
Resubmission - Version 6Manuscript19 Jul 2007
Resubmission - Version 7Manuscript24 Jul 2007
Resubmission - Version 8Manuscript24 Jul 2007
Accepted24 Jul 2007
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.